1. Home
  2. WFCF vs GANX Comparison

WFCF vs GANX Comparison

Compare WFCF & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WFCF
  • GANX
  • Stock Information
  • Founded
  • WFCF 1996
  • GANX 2017
  • Country
  • WFCF United States
  • GANX United States
  • Employees
  • WFCF N/A
  • GANX N/A
  • Industry
  • WFCF Computer Software: Prepackaged Software
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WFCF Technology
  • GANX Health Care
  • Exchange
  • WFCF Nasdaq
  • GANX Nasdaq
  • Market Cap
  • WFCF 59.1M
  • GANX 69.0M
  • IPO Year
  • WFCF 2011
  • GANX 2021
  • Fundamental
  • Price
  • WFCF $13.15
  • GANX $1.58
  • Analyst Decision
  • WFCF
  • GANX Strong Buy
  • Analyst Count
  • WFCF 0
  • GANX 5
  • Target Price
  • WFCF N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • WFCF 5.4K
  • GANX 526.2K
  • Earning Date
  • WFCF 11-11-2025
  • GANX 11-13-2025
  • Dividend Yield
  • WFCF N/A
  • GANX N/A
  • EPS Growth
  • WFCF N/A
  • GANX N/A
  • EPS
  • WFCF 0.39
  • GANX N/A
  • Revenue
  • WFCF $25,604,000.00
  • GANX N/A
  • Revenue This Year
  • WFCF N/A
  • GANX N/A
  • Revenue Next Year
  • WFCF N/A
  • GANX N/A
  • P/E Ratio
  • WFCF $33.41
  • GANX N/A
  • Revenue Growth
  • WFCF N/A
  • GANX N/A
  • 52 Week Low
  • WFCF $9.26
  • GANX $1.36
  • 52 Week High
  • WFCF $13.50
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • WFCF 78.28
  • GANX 39.85
  • Support Level
  • WFCF $12.44
  • GANX $1.55
  • Resistance Level
  • WFCF $12.67
  • GANX $1.78
  • Average True Range (ATR)
  • WFCF 0.20
  • GANX 0.13
  • MACD
  • WFCF 0.07
  • GANX -0.03
  • Stochastic Oscillator
  • WFCF 89.84
  • GANX 6.00

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: